drugset / Trial / NCT04842162

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery

NCT04842162

Phase 2 Recruiting 65 enrolled Gustave Roussy, Cancer Campus, Grand Paris
NaSingle-groupOpen-labelDiagnostic

Summary

Assess the sensitivity of real-time near-infrared fluorescence imaging to detect microscopic residual disease in the operating room after a complete macroscopic surgical resection of head and neck cancers

Timeline

Start
2020-12-15
Primary completion
2026-11
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent

Indications